Area of research
Oncology · Molecular Biology
Research interest
Research interests include Peptidase Inhibition and Analysis, CRISPR and Genetic Engineering, Cancer Research and Treatments, and CAR-T cell therapy research.
The pathways for nanoparticle transport across tumour endothelium
323 Development of nuclear envelope protein-targeting CAR T cells for treatment of hyperproliferative<i>MYC</i>-driven group 3 medulloblastoma
High-content CRISPR screening
High-content CRISPR screening
Context-dependent regulation of ferroptosis sensitivity
A cohesin traffic pattern genetically linked to gene regulation
NOX4 links metabolic regulation in pancreatic cancer to endoplasmic reticulum redox vulnerability and dependence on PRDX4
A Cohesin Traffic Pattern Genetically Linked to Gene Regulation
HAL (Le Centre pour la Communication Scientifique Directe) 2021cited by 20position: last
Cell cycle regulation of mitochondrial protein import revealed by genome-scale pooled bimolecular fluorescence complementation screening
The shieldin complex mediates 53BP1-dependent DNA repair
Map of synthetic rescue interactions for the Fanconi anemia DNA repair pathway identifies USP48
Highly multiplexed and quantitative cell-surface protein profiling using genetically barcoded antibodies
Functional Genomic Landscape of Human Breast Cancer Drivers, Vulnerabilities, and Resistance
System-Wide Modulation of HECT E3 Ligases with Selective Ubiquitin Variant Probes
High-Resolution CRISPR Screens Reveal Fitness Genes and Genotype-Specific Cancer Liabilities
A Dynamic Protein Interaction Landscape of the Human Centrosome-Cilium Interface
Genome-wide CRISPR-Cas9 Screens Reveal Loss of Redundancy between PKMYT1 and WEE1 in Glioblastoma Stem-like Cells
A High Through-put Platform for Recombinant Antibodies to Folded Proteins
MBNL proteins repress ES-cell-specific alternative splicing and reprogramming
A Strategy for Modulation of Enzymes in the Ubiquitin System
A negative genetic interaction map in isogenic cancer cell lines reveals cancer cell vulnerabilities
Regulation of CD133 by HDAC6 Promotes β-Catenin Signaling to Suppress Cancer Cell Differentiation